The Impact of COVID-19 is included in Biosimulation Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Biosimulation Trends and Forecast
The future of the global biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research Institution markets. The global biosimulation market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software, and growing R&D expenditures in the biotechnology and pharmaceutical sectors.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Biosimulation by Segment
The study includes a forecast for the global biosimulation by delivery model, product, application, end use, and region.
Biosimulation Market by Delivery Model [Shipment Analysis by Value from 2018 to 2030]:
• Subscription Models
• Ownership Models
Biosimulation Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Software
• Services
Biosimulation Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Drug Development
• Drug Discovery
• Others
Biosimulation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Pharmaceutical & Biotechnology Companies
• CROs
• Regulatory Authorities
• Academic Research Institutions
Biosimulation Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Biosimulation Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities aCROss the value chain. With these strategies biosimulation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biosimulation companies profiled in this report include-
• Certara
• Dassault
• Advanced Chemistry Development
• Simulation
• Schrodinger
• Chemical Computing Group
• Physiomics
• Rosa & Co
• BioSimulation Consulting
• Genedata
Biosimulation Market Insights
Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.
North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.
Features of the Global Biosimulation Market
Market Size Estimates: Biosimulation market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Biosimulation market size by various segments, such as by delivery model, product, application, end use, and region in terms of value ($B).
Regional Analysis: Biosimulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different delivery model, product, application, end use, and regions for the biosimulation market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biosimulation market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the biosimulation market size?
Answer: The global biosimulation market is expected to reach an estimated $6.8 billion by 2030.
Q2. What is the growth forecast for biosimulation market?
Answer: The global biosimulation market is expected to grow with a CAGR of 13.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the biosimulation market?
Answer: The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software and increasing r&d expenditures in the biotechnology and pharmaceutical sectors.
Q4. What are the major segments for biosimulation market?
Answer: The future of the biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research institution markets.
Q5. Who are the key biosimulation market companies?
Answer: Some of the key biosimulation companies are as follows:
• Certara
• Dassault
• Advanced Chemistry Development
• Simulation
• Schrodinger
• Chemical Computing Group
• Physiomics
• Rosa & Co
• BioSimulation Consulting
• Genedata
Q6. Which biosimulation market segment will be the largest in future?
Answer: Lucintel forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.
Q7. In biosimulation market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the biosimulation market by delivery model (subscription models and ownership models), product (software and services), application (drug development, drug discovery, and others), end use (pharmaceutical & biotechnology companies, CROs, regulatory authorities, and academic research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Biosimulation Market, Biosimulation Market Size, Biosimulation Market Growth, Biosimulation Market Analysis, Biosimulation Market Report, Biosimulation Market Share, Biosimulation Market Trends, Biosimulation Market Forecast, Biosimulation Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Biosimulation Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Biosimulation Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Biosimulation Market by Delivery Model
3.3.1: Subscription Models
3.3.2: Ownership Models
3.4: Global Biosimulation Market by Product
3.4.1: Software
3.4.2: Services
3.5: Global Biosimulation Market by Application
3.5.1: Drug Development
3.5.2: Drug Discovery
3.5.3: Others
3.6: Global Biosimulation Market by End Use
3.6.1: Pharmaceutical & Biotechnology Companies
3.6.2: CROs
3.6.3: Regulatory Authorities
3.6.4: Academic Research Institutions
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Biosimulation Market by Region
4.2: North American Biosimulation Market
4.2.1: North American Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
4.2.2: North American Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
4.3: European Biosimulation Market
4.3.1: European Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
4.3.2: European Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
4.4: APAC Biosimulation Market
4.4.1: APAC Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
4.4.2: APAC Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
4.5: ROW Biosimulation Market
4.5.1: ROW Biosimulation Market by Application: Drug Development, Drug Discovery, and Others
4.5.2: ROW Biosimulation Market by End Use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Biosimulation Market by Delivery Model
6.1.2: Growth Opportunities for the Global Biosimulation Market by Product
6.1.3: Growth Opportunities for the Global Biosimulation Market by Application
6.1.4: Growth Opportunities for the Global Biosimulation Market by End Use
6.1.5: Growth Opportunities for the Global Biosimulation Market by Region
6.2: Emerging Trends in the Global Biosimulation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Biosimulation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biosimulation Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Certara
7.2: Dassault
7.3: Advanced Chemistry Development
7.4: Simulation
7.5: Schrodinger
7.6: Chemical Computing Group
7.7: Physiomics
7.8: Rosa & Co
7.9: BioSimulation Consulting
7.10: Genedata
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Biosimulation Market Report.